Brocair Publishes New Report on Generics Market
Brocair Partners LLC, an investment bank serving the healthcare industry, has published a new report on the generic pharmaceuticals sector.
Featured Articles
BioNeutral to Expand Into Asia
BioNeutral Group, a developer of chemical-based technology, announced that they will form a new wholly owned subsidiary in Hong Kong to commercialize their proprietary chemical formulations throughout Asia.
China Becoming Hot Spot for Western Pharma, Biotech Firms
Asian countries such as India and Japan have gained notoriety for their talented scientists and innovative contributions to the life sciences. Now, a new contender is emerging as a potential industry leader.
Bioject Signs With U.S. Navy for Malaria Vaccine
Bioject Medical Technologies, a developer of needle-free injection systems, has signed a cooperative R&D agreement with the U.S. Navy to use Bioject’s technology in a malaria vaccine the Navy is developing.
Electro-Optical Announces MelaFind Study Results
Electro-Optical Sciences has announced positive results in a clinical trial of the MelaFind System, a handheld imaging device that detects melanomas at an early stage.
Psilos Releases Forecast for Healthcare Industry
Healthcare venture capital firm Psilos has released their first annual report on the issues that will shape healthcare investing in 2009 and beyond.
AstraZeneca’s Heart Drug Beats Plavix in Phase III Study
Blood-thinning drug Plavix racks up over $8 billion in annual sales, but the blockbuster medication may have some new competition.
Covidien to Buy VNUS Medical Technologies
Forbes reports that medical device maker Covidien is buying VNUS Technologies for $440 million in cash.
FDA Approves Fanapt for Schizophrenia Patients
Maryland-based Vanda Pharmaceuticals announced that the U.S. Food and Drug Administration has approved Fanapt (otherwise known as iloperidone) for the acute treatment of adult patients with schizophrenia.
Focal Drug Delivery Helps Deadly Brain Tumor, Study Shows
A method of delivering chemotherapy drugs into a deadly type of brain tumor extended the lives of patients in early clinical trials.